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E xec u ti ve S ummar y
Childhood asthma is a serious and chronic health issue that affects one in seven U.S. children and
their families, compromising their health and quality of life and placing a heavy financial burden on
families as well as an enormous strain on the health care system.
Treating, managing, and ultimately preventing and reducing the burden of asthma represents a
critical test of the ability of the U.S. health system – health insurers, clinical care providers, and public
health agencies – to work together. Our investigation found that, as a country, we already know
enough to act and improve life for the millions of children living with asthma; we’re just not aiming
high enough. If we did, the nation would create and put into place an array of policy reforms that
together could translate into real change.
Research has shown the effectiveness of comprehensive asthma treatment and management: (1) high
quality clinical care; (2) case management and educational counseling; and (3) community and home
interventions that help families reduce the environmental triggers that can cause or worsen asthma.
For comprehensive asthma treatment and management to reach children in need, several elements
are essential, and collaboration and communication are key:
• Stable and continuous health insurance;
• H
 igh quality clinical care, case management, and asthma education available for all children,
including those who remain ineligible for insurance coverage;
• T he ability to continuously exchange information and monitor progress, using as much as
possible health information technology (HIT);
• Reduction of asthma triggers in homes and communities; and
• Learning what works and increasing knowledge.
This report lays out the facts and offers specific policy recommendations for success that could change
the face of childhood asthma in America. These recommendations aim to make better use of programs
and policies already in place, such as Medicaid and the Children’s Health Insurance Program (CHIP), as
well as private sector insurance coverage and existing public health programs. The recommendations
also underscore the importance of careful research – scientific, practical, and community-based – in
order to continue to learn what works best and strengthen knowledge for future action.
In a reformed health system, these initial efforts are not wasted tools. Instead, they become the
critical platform on which further interventions would rest.

What We Know
Asthma is extraordinarily prevalent. Asthma represents the second most prevalent childhood
condition and the single most common chronic condition among children. In 2008, one in every seven
children — 10.2 million — had lifetime asthma, and one in 11 children — 6.95 million — had current
asthma. Prevalence rates are even higher among the 24 million children at risk for medical underservice
as a result of low family income and residence in communities that lack adequate primary health care
resources.
Asthma prevalence is growing. The proportion of children with asthma steadily grew over the
1997-2008 time period. Nearly 60 percent of children with diagnosed asthma have experienced an
attack within the previous 12 months.
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Asthma is nationwide, but certain states and communities experience
especially serious burdens. For example, nearly one in five children living
in Puerto Rico has asthma. Community-level data are largely lacking, but the
existing research suggests that in some communities as many as 40 percent
of children are living with asthma. Asthma appears to be equally prevalent in
rural and urban areas.
Low income and minority children bear the heaviest burden of
asthma and its consequences, including death. One in three children
living with asthma is poor, and 60 percent have family incomes below twice
the federal poverty level. Health care providers that specialize in treating low
income and medically underserved children report particularly high levels of
asthma. Community health centers in 2007 reported that 20 percent of their
pediatric patients had asthma. Compared to white non-Hispanic children,
asthma is 60 percent higher among African-American children and nearly
300 percent higher among Puerto Rican children.
Asthma is extremely costly. Asthma adds nearly 50 cents to every health
care dollar spent on children compared to children without asthma. In 2006,
the nation spent eight billion dollars alone on treating childhood asthma.
Compared with children who do not have asthma, pharmaceutical expenditures
are nearly four times higher for asthmatic children, outpatient office-based
expenditures are 55 percent higher, and emergency department care is 40
percent higher. Asthma was associated with 13.6 percent of all pediatric
hospitalizations in 2006, and children with asthma who use emergency
department care are significantly more likely than children without asthma
to require inpatient admission (65 percent v 44 percent).
Racial and ethnic disparities in access to effective treatment are
widespread. Despite the need and risk, health care expenditures are the
lowest for the children most at risk. African-American children and Hispanic
children receive about half as much outpatient care and medication management
than white children. Yet because they are more likely to be low income and
medically underserved, Hispanic children also experience the highest hospital
emergency department expenditure rate.
Insurance is key, but we may be missing many children. An estimated
nine percent of all children living with asthma remain completely uninsured; we
estimate that nearly 600,000 are eligible for Medicaid or CHIP but unenrolled.

It Doesn’t Have to Be This Way; We Know Enough
to Act
Asthma is a bellwether of health system performance, and progress in
reducing and controlling asthma is a sign of health system improvement.
Effective management of asthma spans the entire health system and thrives
on smooth coordination and effective communication among key actors:
health insurers, health care providers, public health agencies, schools, state
and local environmental programs, and community programs.
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Childhood
asthma is
a serious
and chronic
health issue
that affects
one in seven
U.S. children
and their
families…

E xec u ti ve S ummar y
…progress on
asthma depends
on learning what
works in the
real-world —
in and outside
of health care
settings

Certain factors that trigger asthma, such as genetic predisposition, history of
allergies, or gender, may not be amenable to change. But key risk factors are
open to change. These include inadequate access to high quality medical care,
inadequate health education for families of children with asthma, and failure to
address indoor asthma triggers and outdoor environmental risks.
Over the long term, progress on asthma depends on learning what works in
the real-world — in and outside of health care settings — and advancing our
scientific understanding of the condition and its effects.
The elements for improving childhood asthma outcomes include the following:
• S
 table and continuous health insurance. All children — especially
those with asthma — must have stable, continuous, and high quality
health insurance coverage, the foundation of comprehensive health care.
Some 1.17 million children - an estimated nine percent of all children living
with asthma - remain completely uninsured. We estimate that nearly
600,000 are currently eligible for Medicaid or CHIP but unenrolled.
Medicaid and CHIP are essential to the health of low income children;
no eligible child with asthma should go without coverage.
• H
 igh quality clinical care, case management, and asthma
education available for all children, including those who remain
ineligible for insurance coverage. The health care system must
perform well, getting the right care to children and their families at the
right time. High quality care is essential for all children, including those
who remain ineligible for coverage. For children at risk for medical
underservice, access points through community health centers, children’s
hospitals, public hospitals and health systems, and other sources of
community care are essential. High quality care means having a regular
source of medical care that offers a medical home to children and their
families, access to specialty care, preventive care and prompt treatment
for acute episodes, ongoing case management and health education, and
linkages to home-based and environmental services. Increasingly, having
a medical home also will mean having a provider with the ability to make
meaningful use of health information technology and with the ability to
exchange essential information with community public health agencies,
and school systems, particularly those with on-site asthma management
programs. More generally, educators and school health care staff must
also be able to manage asthma in school settings.
• T
 he ability to continuously exchange information and monitor
progress, using as much as possible health information technology
or HIT. Providers, insurers, and public health agencies must be able to
collaborate on efforts to monitor communities for asthma prevalence, as
well as on the progress of children in treatment. Children’s health care
providers need to be able to exchange information with other providers,
such as hospitals that provide emergency or inpatient treatment
for acute episodes. All health care providers need to be able to
communicate treatment information not only to insurers but to public
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health agencies, which must be able to monitor communities both for asthma prevalence and
the availability of effective clinical and community preventive services. Implementation of the
Medicaid HIT incentive provisions contained in the HITECH Act will be of crucial importance in
assuring that pediatric care benefits from HIT, because of the high proportion of U.S.
children enrolled in Medicaid and CHIP.
• R
 eduction of asthma triggers in homes and the communities. Asthma is triggered by
specific risk factors found in homes and communities. Combining high quality clinical care with
health education in the home works to reduce environmental health risks. We just are not
doing enough of it. Public health agencies, housing authorities and environmental agencies
must promote evidence-based interventions and services that are essential to reducing the many
environmental asthma triggers that lie beyond the control of any one family and fall outside of
traditional “health care” interventions.
• L earning what works and increasing knowledge. Much work has been done to build the
knowledge base for what is needed, but what we know needs to be continuously tested and refined
in order to make health care as effective as possible. We need further basic research into the science
of asthma so that new and more effective treatments can be developed. Despite the involvement
in asthma-related research on the part of numerous agencies at the United States Department of
Health and Human Services (HHS), there is no strategic plan for asthma research that lays out a
strategy moving across the continuum of scientific discovery and translation into routine practice.

How to Achieve the Elements for Improving Asthma Outcomes:
Using Available Tools and Aiming Higher
We have numerous tools for improving asthma treatment and management, while reducing the
burden of asthma on children and families. But we need to aim higher through innovation in existing
programs as well as through active coordination across the major federal agencies whose programs
and strategies influence national asthma policy, particularly for the most at-risk children. The policy
innovations launched today will lay important groundwork for broader transformations to come
through comprehensive health reform.
Today’s federal health programs offer specific policy levers that can be used to enable better performance
for children with asthma. Numerous federal agencies play a crucial role in achieving a robust response
to the great challenges posed by childhood asthma: HHS; the United States Environmental Protection
Agency (EPA); and the United States Department of Education (ED).
We present specific and feasible policy recommendations for each element identified as key to
improving asthma outcomes:
Stable and Continuous Health Insurance
•

9

 ake continuous Medicaid and CHIP enrollment a part of every eligible child’s asthma
M
treatment plan developed by the child’s health care provider team. Approximately a half million
children with asthma are eligible but unenrolled in Medicaid or CHIP — and with millions more
currently enrolled in Medicaid or CHIP but at risk for breaks in coverage — Medicaid and CHIP
enrollment should be viewed as part of the treatment plan for every eligible child with asthma.

E xec u ti ve S ummar y
•

E ncourage all states to expand Medicaid and CHIP to
at least 300 percent of the federal poverty level and to
adopt new options to fully cover legally resident children.
With expanded eligibility for coverage comes the
potential for more stable and higher quality health care.
Today seven states cover all children with family incomes
up to 300 percent of the federal poverty level. Were all
states to increase coverage to 300 percent of the federal
poverty level, an additional one million children beyond
those currently eligible would be eligible for Medicaid or
CHIP. Of this number, an estimated 180,000 would be
previously uninsured children with asthma. Expansion
of public insurance to reach all eligible children nationally
would represent an enormous advance and one
consistent with broader health reform.

•

E ncourage all states to adopt Medicaid and CHIP
enrollment and retention reforms, especially reforms
aimed at making enrollment and retention activities
possible through community health care providers,
schools, and other locations where children and families
can easily apply for, and renew, coverage. Outreach
funding should be made available through Medicaid
and CHIP, and community providers should partner with
hospitals furnishing acute care to assure that no child
is missed.

•

 ake enhanced asthma treatment and management a
M
specific focus of quality performance improvement in
Medicaid and CHIP. The 2009 CHIP legislation increases
the focus on quality performance improvement among
Medicaid and CHIP providers through the development
of national performance measures and alignment of
these measures with provider payment incentives. Existing
performance measures related to childhood asthma
should be strengthened to more closely align with
the National Heart Lung and Blood Institute’s (NHLBI)
National Asthma Education and Prevention Program
(NAEPP) clinical treatment guidelines, particularly in
the areas of health education and case management.
Medical home and accountable care organization
demonstrations that utilize these measures to incentivize
provider performance should be encouraged.

 igh quality clinical care, case management, and
H
asthma education available for all children, including
those who remain ineligible for insurance coverage.
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•

 reate an HHS-led, cross-agency, Administration-wide
C
national plan for changing childhood asthma outcomes.
Despite a wealth of programs and the importance
of HHS programs to ensure accessible and quality
care for children most at risk for asthma and its
consequences, there is no current joint HHS guidance
that comprehensively addresses childhood asthma,
although HHS did issue a strategic plan on asthma in May
2000. The plan describes the role of the Department
in pursuing priority public health actions to eliminate
disparities and reduce the overall impact of asthma and
to address urgent needs for research in order to better
understand the causes of the epidemic and develop
preventive interventions to address these causes. The
need for such leadership and guidance is particularly
acute today in the case of programs overseen by the
Centers for Medicare and Medicaid Services (CMS)
because of the role of Medicaid and CHIP in financing
systemic improvements in pediatrics. The creation of
such guidance could be led by a Secretarial-level
workgroup consisting of CMS, the Health Resources
and Services Administration (HRSA), the Centers for
Disease Control and Prevention (CDC), the Indian
Health Service (IHS), the Office of the National
Coordinator for Health Information Technology
(ONCHIT), in collaboration with the Departments of
Education(ED) and Housing and Urban Development
(HUD) and the EPA.
T hrough a transparent process that involves consumers,
health professionals, payers, and experts in public health
practice, health information, health care financing,
school health, community health, and clinical treatment
for children with asthma, a Secretarial work-group could
develop comprehensive guidance. Such guidance could
address the plethora of daily practical issues that arise
when states and localities attempt to make better and
more coordinated use of separate public programs in
order to improve quality and efficiencies, reduce disparities
in health and health outcomes, reduce public health
threats, and improve overall population health. Practical
guidance would greatly help translate the promise of
public programs into real-world change. Such guidance
could address with clarity:
1. T he clinical services and treatments that Medicaid
and CHIP will pay for and the treatment settings in
which payment can be made;

2. S pecial financing opportunities in the case of
community-based programs and health care providers
that treat a disproportionate number of children with
asthma and that are located in medically underserved
rural and urban communities;
3. O
 ptions to finance outreach, health education, and
case management in community settings;
4. D
 eveloping and using public health and practice
registries related to childhood asthma and federal
resources available for such activities;
5. R
 esources available for mitigating home and
environmental threats;
6. T he meaningful use of HIT in the context of pediatrics
generally and childhood asthma in particular, because
of the extent to which the quality of asthma care can
benefit from improved health information exchange;
7. P rivacy and security considerations in adapting HIT
to childhood asthma, which must cross clinical care,
payers, educational systems, environmental practice,
and public health practice.
A far-reaching and visionary cross-agency initiative
would do much in our view to encourage change at
every level, while also attracting broad private sector
participation because of the cost of childhood asthma
to all payers.
•

 ake performance improvement in childhood asthma a
M
key program aim for community health centers and the
Indian Health Service (IHS). Together, community health
centers and the IHS reach millions of the children most
at risk for asthma. Performance in pediatric asthma
management and treatment should become a basic
mechanism for measuring health care performance.

The ability to continuously exchange information
and monitor progress, using as much as possible
opportunities presented by HIT.
Enhance asthma monitoring through model registries.
Asthma registries are essential to population surveillance,
monitoring the accessibility and quality of care as well
as patient outcomes, and tracking critical incidents. The
CDC, in collaboration with HRSA’s Bureau of Maternal
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and Child Health and HHS’ Assistant Secretaries for
Health (ASH) and Preparedness and Response (ASPR),
could develop special guidance on asthma registries that
encourages the development and implementation of
uniform registry systems in all states and communities
with the capability of providing accurate data on
prevalence, incidence, and treatment by race, ethnicity,
age and gender, and primary language spoken, so that
over time, an accurate and current national and community
picture of childhood asthma will emerge.
 eduction of asthma triggers in homes and
R
the communities.
Encourage public health agencies, housing authorities
and environmental agencies to promote evidence-based
interventions and services that are essential to reducing
the many environmental asthma triggers that lie beyond
the control of any one family and fall outside of
traditional “health care” interventions.
Learning what works and increasing knowledge.
Promote a strengthened and diversified Administration–
wide research agenda to include basic, clinical and
translational/implementation investigations.
Numerous federal agencies are involved in asthma
research, but there is no coordinated strategic agenda
that spans basic and health services research and that
lays out a broader vision, beginning with what is known
today, and focusing on what needs to be known in
practice tomorrow, and where knowledge needs to go
over the long term. With the emerging consensus
around the importance of comparative and clinical
effectiveness research, and in light of the 2009 reforms
enacted by Congress to advance such research, it is
time to fulfill the 2000 Congressional directive for a
comprehensive asthma research agenda, bringing a
fresh eye to the issue and coordinating the agenda to
encompass both research that advances daily practice
with research that will deepen knowledge about asthma
and its causes.

In t roduc tion

Introduc tion
“Looking back to my asthma days when I
was a child, I think I have blocked a lot of it
out. I was sort of traumatized by it, I think,
in part because I was older when I was
diagnosed, probably nine, and I used asthma
medications (inhaler/nebulizer) until I was
16 or 17. I was self-conscious about it. I only
had to go to the emergency room once for
an asthma attack that turned into pneumonia
and that required steroid treatment. I missed
a month of school because of it. Although I
did not have frequent attacks, each one was
terrifying, a sort of panicked, hot-all-over
feeling of trying to get enough air. I think the
worst of it was being unable to do things
like run and feeling “sickly.” Asthma made
me feel fragile, as if my respiratory system
was untrustworthy – and breathing is pretty
fundamental!”
— Meagan,
diagnosed with asthma at age 9
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Asthma is a serious and chronic condition that can be
fatal. Grasping the magnitude of the condition requires
translating asthma statistics into real-life events and
outcomes. More than 10 million children have lifetime
asthma, millions of whom have suffered an attack in the
past year.i Every day children are rushed to the emergency
department, and some are hospitalized as they struggle
to breathe.ii Childhood asthma exacts a major toll on child
health and family well-being.
Asthma places a heavy burden on children and families and
is enormously costly to the health care system and society
as a whole. For this reason, addressing the problem of
childhood asthma is important at any time. But the
challenge of effectively treating asthma at both the personal
and social levels takes on added dimensions in a reform
environment, as the nation looks for ways to expand
coverage while attempting to bend the curve on health
care spending, learning what works and adding to scientific
knowledge, promoting system transparency, and improving
population health, especially for those at highest risk of
illness, disability, and death. Childhood asthma is a
bellwether condition whose effective treatment tests
our ability to make real change. Its management demands
a team effort by families, health care professionals, and
communities. A decisive effort to lessen the burden
of asthma offers an unparalleled strategy for assessing
over time whether the health system is moving in the
right direction.
Unmanaged asthma flourishes at the intersection of
system failure: failure on the part of health care providers
to detect it and provide appropriate, guideline-based
clinical management and a failure of some payers to
properly incentivize these results; failure on the part of
public health and social services programs to enable and
empower families to address asthma triggers; failure of
public health to vigilantly monitor communities for its
presence and the quality of treatment; failure to invest in
community prevention strategies; and failure to strategically
plan for and invest in basic and health services research.
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This report lays out the key facts – the extent of the
problem of childhood asthma, the children at highest risk,
what works, and what it will take to make what works
available to all children. It finds that the tools we need are
well within our grasp; what we need to do is use them
and aim higher.
For comprehensive asthma treatment and management to
reach children in need, several elements are essential, and
collaboration and communication are key:
• Stable and continuous health insurance;
• H
 igh quality clinical care, case management, and
asthma education available for all children, including
those who remain ineligible for insurance coverage;
• T he ability to continuously exchange information and
monitor progress, using as much as possible health
information technology or HIT;
• R
 eduction of asthma triggers in homes and
communities; and
• Learning what works and increasing knowledge.
This report begins by laying out the dimensions of the
challenge, as well as what is known about how to address
asthma. It then examines what works and sets forth a
series of policy recommendations aimed at translating
this knowledge about what works into reforms that can
benefit all children living with asthma.
This report focuses on public policy reforms, building on
evidence to date from the peer-reviewed literature, as
well as on prior reports resulting from expert consensus
reviews, and relevant policy reports (including the American
Lung Association’s “A National Asthma Public Policy
Agenda,” 2009; the Public Health Foundation’s “We Can
Do Better: Improving Asthma Outcomes in America,” 2009;
and the RAND Corporation’s “Health: Improving Childhood
Asthma Outcomes in the United States A Blueprint for
Policy Action,” 2001.) iii

W ha t We K now

W ha t We K now
The Magnitude of the Problem
Asthma is a chronic lung disease that cannot be cured, although treatment options exist to manage the
disease and its symptoms.iv Asthma inflames and narrows the bronchial tubes, the lungs’ airways.v It
causes recurring periods of wheezing (a whistling sound when breathing), chest tightness, shortness of
breath, and coughing, which tend to occur at night or early in the morning.vi Asthma affects people of
all ages, but it most often begins in childhood.vii Even when children with asthma are feeling fine, the
condition can flare up at any time. Asthma can impose serious limitations on the normal activities of
childhood and can lead to death.viii

Prevalence of Asthma
There is no uniform system currently available that — in real time and at a community level — can
measure the presence of asthma among children as well as the proportion of children with asthma
who are receiving appropriate treatment. Instead, there are a series of studies that provide insight
into childhood asthma prevalence, which show a range of prevalence rates from 9–14 percent
depending on the ages of children included and the definition of asthma (e.g., ever diagnosed with
asthma or lifetime asthma vs. current asthma). In this report, we use data largely drawn from the
National Health Interview Survey (NHIS) and the Medical Expenditures Panel Survey (MEPS), employing
other studies at various points to illustrate important population differences and patterns.
Asthma is not only serious, it is widespread. In 2008, 14 percent of all children (one in seven) ix
had lifetime asthma and 9.4 percent of all children (one in 11) had current asthma at the time when
they were surveyed, making it second only to childhood obesity in prevalence (Figure 1). (Evidence
suggests a potential link between childhood obesity and the presence of asthma.) x
Figure 1: Asthma is the Second Most Prevalent Child Health Condition, 2005-2006

18%

8.2%

8%

17%

8.9%

4.6%

9%

8.3%

*

9.3%
Low Birth Weight (<5lb 8oz)

5%

Emotional & Behavioral Difficulties (Ages 4-7)
Activity Limitation due to Chronic Condition (Ages 5-17)
Overweight (Ages 6-17)
Asthma (Ages 0-17)

2005 (n=12,523 children)

2006 (n=9,837 children)

* The increase in the percentage of children born LBW at birth is the only statistically significant difference between 2005 and 2006.
Source: Center for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Survey. 2005-06
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Not Only Common, Also Costly

Asthma adds

Serious asthma is not only common (Figure 1), it is costly (Figure 2). On an
annual basis, asthma and other pulmonary diseases represent the single most
common chronic condition for which children are treated (12.9 million in 2006
according to MEPS data).xi Furthermore, compared to other childhood diseases,
childhood asthma – particularly when poorly managed – is extremely costly to
treat (Figure 2).

about 50 cents

Figure 2: Asthma Costs for Children, 2006
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Mental Disorders

$6.1

Asthma CCPD

$2.9

Trauma
Acute Bronchitis and URI
Infectious Diseases

Medical Expenditures

(in dollars, billions)

Source: Soni, Anita, Statistical Brief #242, April 2009, Rockville, MD: AHRQ

Asthma adds about 50 cents to every health care dollar spent on children
with asthma compared to children without asthma. Average total health care
expenditures in 2006 (which included pharmaceuticals, office-based visits,
outpatient hospital visits, emergency room visits, and inpatient visits) for
children with asthma were $1,906 compared to $1,263 for children who were
not diagnosed with asthma (Figure 3), while average health care expenditures
for all children ages 0 to 17 were $1,330 per child in 2006. Compared with
children who do not have asthma, pharmaceutical expenditures are nearly
four times higher for asthmatic children, outpatient office-based expenditures
are 55 percent higher, and emergency department care is 40 percent
higher (Figure 3). Asthma was associated with 13.6 percent of all pediatric
hospitalizations in 2006, and children with asthma who use emergency room
care are significantly more likely than children without asthma to require
inpatient admission (65 percent v 44 percent) xii. In 2005, in a sample of
community hospitals in 23 states, asthma was found to be the second most
common cause of emergency department visits that led to hospitalizations.xiii
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W ha t We K now
Figure 3: Pediatric Health Care Spending - Children With and Without Asthma, 2006
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Source: Dor, A. Rochard P., Tan, E.(2009). Analysis of 2008 MEPS Data. Washington, DC: GWU.

Not a Quiet Presence
Asthma is not a quiet presence. Nearly one out of every 16 children has experienced an asthma
attack in the preceding 12 months (Figure 4), and in the case of children already diagnosed with
asthma, 60 percent have experienced an attack within the past year. These figures have increased
slightly over the past decade as has the proportion of children with asthma (Figure 4).
Figure 4: Asthma Attacks in the Past 12 Months, 1997-2006
Ever diagnosed with asthma

11.4%

13.5%

Current asthma
Had at least one asthma attack
in the past 12 months

9.3%

8.8%
5.4%
1997

5.6%
1998

1999

2000

2001

2002

2003

Source:Centers for Disease Control and Prevention. National Center for Health Statistics. National Health Interview Survey.
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Certain Children Face a Higher Asthma Burden
Asthma is a nationwide problem, but its prevalence varies geographically, socio-economically,
and by race and ethnicity.
Geography
• M
 ore than a third of children (37 percent) in the United States aged 0-17 live in the South, and 34
percent of children with asthma live in the South (2008 Census and 1996-1997 and 1999-2000
MEPS data). In the rest of the country, children with asthma are otherwise evenly distributed
among the three regions (Northeast: 20 percent, Midwest: 23 percent, and West: 23 percent).xiv
• A
 cross the country, state asthma prevalence varies, with even the lowest ranges still unacceptably
high, and many states reporting 10-12 percent prevalence (Figure 5). An astonishing 19 percent
of all Puerto Rican children have asthma. While the majority of children with asthma live in
metropolitan statistical areas (MSAs), 20 percent of all children with asthmaxv live outside a
metropolitan region, in communities that are more sparsely populated and more highly rural.xvi
Figure 5: Childhood Asthma is National in Scope but More Common in Certain States, 2003
• S ystematic community-level
information about asthma
WA
ME
ND
prevalence is lacking. But the
MT
VT
MN
OR
NH
data that do exist suggest
ID
WI
NY MA RI
SD
CT
MI
WY
that certain communities can
PA
IA
NJ
NV
NE
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MD
be considered risk-epicenters
DC DE
IL IN
UT
WV
CO
VA
CA
KS
MO
KY
because the prevalence of
NC
TN
asthma is so far above the
OK
AZ
AR
SC
NM
5.7
7.4
%
national average. For example,
MS AL
GA
LA
TX
in Massachusetts, where the
7.5 - 8.6 %
FL
Department of Public Health
AK
8.7 - 10.0 %
has mapped asthma in 350
HI
10.1 - 11.9%
communities, one community
Source: Analysis of National Survey of Children’s Health by Akinbami et al., PEDIATRICS Volume 123,
(West Brookfield) showed a
Supplement 3, March 2009 S131 www.pediatrics.org. Sample included 102,353 child-level interviews
childhood asthma prevalence of
completed nationally, and approximately 2,000 interviews collected per state ranging from 1,483-2,241.
more than 43 percent for the
2006-2007 school years, with
four other communities having prevalence above 20 percent, and the remaining hovering between
5-15 percent.xvii In Los Angeles County, California in 2008, the prevalence of childhood asthma was
14.2 percent and emergency department visits for children aged 0-17 were 69 per 10,000 residents.xviii
• U
 rban/rural information is also not widely available. But among children who receive their
care from community health centers, which report cases, the prevalence of asthma is virtually
identical, regardless of urban/rural setting (Figure 6). However, a higher proportion of pediatric
patients of rural health centers have experienced an asthma attack.
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Figure 6: Urban and Rural Children Seen at Health Centers Have Comparable Rates of Asthma, 2002

82%

78%
60%

58%

42%

40%
18% 22%

Urban
Rural

Asthma
(n=445)

No Asthma
(n=1,802)

Asthma Attack
(n=217)

No Asthma Attack
(n=227)

Source: 2002 CHC User Survey, HRSA, DHHA. Sample was weighted and included data from 2,129 interviews and augmented by 3,028; medical

Poverty, race, and ethnicity
As with other preventable and treatable conditions, poverty is a significant asthma predictor.
Moreover, racial and ethnic disparities are clearly evident.
• 2
 0 percent of children seen at health centers are reported to have asthma. Health center patients
are far more likely to be low income (91 percent have family incomes below 200 percent of the
federal poverty level of $44,100 for a family of four in 2009) than the general population, and
are significantly more likely to be members of racial and ethnic minority groups (37 percent were
white non-Hispanic, 36 percent Hispanic, 23 percent African-American, 3 percent Asian, and 1
percent Native American in 2006).
• L ow income children account for approximately 37 percent of all U.S. children,xix but they
represent nearly three in five (58 percent) children with asthma (Figure 7).
Figure 7: Children with Asthma are Disproportionately Low Income, 1996-2000
Children with Asthma by Percent FPL, 1996-2000

All Children by Percent FPL, 2000

5%

8%
14%

31%

34%
17%

19%
28%
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15%

N=982

100-124
125-199
200-399

29%

N=72.5

Source: Kim et al. (2009). Health Care Utilization by Children with Asthma, Preventing Chronic Disease Vol. 6: No. 1 AND Medical Expenditure Panel Survey (2000).
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African-American children are nearly seven times as likely as white children
to experience death from asthma (Table 1). Asthma prevalence appears to be
higher not only among African-American children but also among American
Indian, and it is particularly elevated among Puerto Rican children.xx The
consequences of asthma also appear to be greater for minority children, with
more missed days of school or work, increased rates of hospitalizations and
emergency room visits and elevated risks for mortality.xxi

Children Ages 0-17

Prevalence

Deaths

(2004-2005)

(percent of children with
current asthma at time of
survey)

(per 1 million children)

8.7

2.4

Black

12.8

9.0

White

7.9

1.3

American Indian/
Alaska Native

9.9

—

Asian

4.9

—

Hispanic

7.8

1.5

Puerto Rican

19.2

—

Mexican

6.4

1.3

Non-Hispanic Black

12.7

8.8

Non-Hispanic White

8.0

1.2

Race

Race/Ethnicity

— = data not available/ sample too small
Source: Akinbami et al., PEDIATRICS Volume 123, Supplement 3, March 2009 S131 www.pediatrics.org

Lower health care expenditures reflect differences in both utilization and cost.
Health care expenditures for African-American children with asthma averaged
$1,153 in 2006, a spending level 49 percent less than the average amount
spent on white children with asthma (Figure 8). This disparity is largely
explained by lower expenditures on pharmaceutical and office-based services;
on average, health expenditures for African-American children with asthma
were 47 percent lower for pharmaceuticals and 46 percent lower for officebased care (Figure 8). Similar disparities can be seen in the case of Hispanic
children: as with African-American children, this disparity is largely explained
by lower pharmaceutical and office-based expenditures. In contrast, in the
case of Hispanic children with asthma, expenditures for emergency room care
were more than double (103 percent) the ER expenditures for white children
with asthma.
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Table 1. Childhood Asthma Prevalence by Race and Ethnicity
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Figure 8: Health Expenditures are Lower for Minority Children, Particularly for Pharmaceutical and
Outpatient Care, while Emergency Room Expenditures are Higher, 2006

Expenditures per Child

$2,400
2,000
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1,600
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Hispanic

1,200

Other

800
400
0

Total
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Source: Dor, A., Richard, P., Tan, E. (2009) Analysis of 2006 MEPS Data. Washington, DC: George Washington University.
Note: White children with asthma are the reference group. Statistical significance is indicated through the p-value: * <.1 ** <.05 *** <.01

Although differences in expenditures between the groups in Figure 8 may be partly the result
of variations in health care costs across communities, further analysis suggests that disparities in
expenditures tend to reflect disparities in the actual level of care received. While the average AfricanAmerican child with asthma made 2.6 office-based visits and annual visits averaged 3.6 for Hispanic
children, white children showed an annual visit rate in 2006 of 6.0 visits.

Asthma Risk Factors
Asthma is the result of many factors. Some are not controllable. Others, however, are amenable
to intervention.

Factors That Cannot Be Controlled
Among children, certain immutable characteristics, such as gender and genetic predisposition,
seem to be predictors of asthma. A history of allergies also appears to be a predictor (Figure 9). For
children with these risk factors, paying attention to controllable risks may be especially important.
Figure 9: Non-Controllable Asthma Risk Factors Among Children
Risk Factor
Gender
Race
Ethnicity
Genetic
Predisposition
Individual History
of Allergies
Family History of
Allergies & Asthma
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Boys have asthma more often than girls.
Asthma is more common among black children than white children.
Asthma is more common among certain Hispanic children than non-Hispanic children.
Children with a genetic predisposition to asthma have an inherent tendency to have bronchial
tubes overreact.
Children with an allergy are more likely than other children to develop asthma.
Children with asthma and allergies often come from families who have had allergies
and asthma.

Factors That Can Be Controlled
A major body of research into the effective management and treatment of
asthma underscores five major risk factors that can be controlled or changed
through intervention:
• Inadequate access to appropriate, high quality health care and case
management;
• A
 failure to address the indoor air environment and other indoor
asthma triggers;
• F ailure to systematically address outdoor environmental triggers that
affect communities in which children live and grow;
• T he absence of a means for monitoring asthma prevalence and
treatment in order to effectively deploy resources; and
• A coordinated research strategy.
Inadequate Access to Appropriate Health Care
Access to appropriate health care for children with asthma begins with stable
and comprehensive health insurance that makes care accessible and affordable
and which has been shown to have a significant impact on health care
utilization and health outcomes.xxii Yet an estimated eight million children
are uninsured, and 70 percent of these children are thought to be eligible
for CHIP or Medicaid but not enrolled. Millions more experience lapses in
health insurance coverage as a result of changing family income and living
circumstances, both of which can affect coverage. Low income children with
asthma are estimated to be somewhat less likely than those without asthma
to be uninsured (Figure 10). But even among these children, nine percent
have been estimated to be uninsured. Using 2006 data, this translates into
1.17 million uninsured children with asthma (out of a total of 12.9 million
in 2006).
Figure 10: Nine Percent of Children with Asthma are Uninsured, 1996-2000
Children with Asthma, 1996 - 2000

9%

All Children, 1996 - 2000

Uninsured

15%

Public Only

28%

63%

N=982
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21%

Private Only/Public

64%

n=65.4 Million

Source: Kim et al. (2009). Health Care Utilization by Children with Asthma, Preventing Chronic Disease Vo. 6: No. 1 and Medical Expenditure Panel Survey Data, 1996-2000.
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The evidence shows that uninsured children with asthma receive fewer office and outpatient visits,
prescriptions, and preventive checkups than publicly-insured children (Figure 11).xxiii

Average Number of Visits/Prescriptions
in 2 Years

Figure 11: Uninsured Children with Asthma Use Fewer Services, 1996-2000
8
7
6
5
4
3
2
1
0

Office & Outpatient Visits
Prescriptions
Preventive Checkups

Uninsured*

Publicly Insured

Privately Insured

Source: Kim et al. (2009). Health Care Utilization by Children with Asthma, Preventing Chronic Disease Vo. 6: No. 1

Even if only half of uninsured children with asthma are eligible for Medicaid or CHIP (a lower figure,
given their higher rate of public insurance coverage), this lower estimate nonetheless means that 4.5
percent of all children with asthma (nearly 600,000) may be uninsured yet eligible for Medicaid or CHIP.
Beyond insurance coverage is the question of whether health care is accessible. Using data on the
prevalence of medical underservice among the population, we estimate that approximately 24 million
children live in urban and rural communities that are classified as medically underserved because of the
shortage of primary health care, the higher poverty and health risks these communities experience, or
a combination of these factors. Not surprisingly, because low family income is a predictor of medical
underservice, among publicly-insured children with asthma, reliance on emergency departments is
elevated compared to privately-insured children.xxiv
Even where access exists, care may be clinically incomplete and inadequate. It has been estimated that
less than 50 percent of children with asthma receive quality care, indicating a severe under-provision
of recommended clinical services.xxv Expert guidelines from the NHLBI/NAEPP (Figure 12) present
comprehensive recommendations on clinical practice standards that build on the best evidence.

Even where access exists, care may be clinically
incomplete and inadequate. It has been estimated
that less than 50 percent of children with asthma
receive quality care.
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Figure 12: Preventing, Diagnosing, Treating and Managing Asthma
Prevention:

Treatment:

- Daily preventive medication (see Treatment, to the right)

- A sthma treatment plan tailored to the child to control
asthma daily over the long term (daily controller medicine,
e.g., inhaled corticosteroid with spacer)

- Health education of children and their families
- Environmental remediation in the home to address triggers

- A sthma action plan tailored to the child to treat asthma
attacks when they occur (quick relief medicine,
e.g., albuterol)

Diagnosis:

Management:

- Routine checkups, including clinical assessments (there is
currently no sensitive and specific diagnostic test), with a
recommended frequency of checkups determined by
clinical judgment depending on how a child’s asthma
is classified:

- Child and family follow a plan, which includes
pharmacologic therapy, tailored to the child to
control asthma

•

•

E very six months for children with intermittent or mild
persistent asthma that has been under control for at
least three months.
 ore often than every six months for children with
M
uncontrolled or severe persistent asthma or for
children who need more supervision.

- Spirometry

- Primary care and specialist physicians teach skills to use
child’s asthma treatment and action plans
- Nurses, social workers, community health workers conduct
regular home visits to provide ongoing asthma education,
periodic health and environmental risk assessment, and
environmental remediation
- Documentation of all encounters for monitoring
and evaluation

- Peak expiratory flow (PEF)
- Chest x-ray, sweat test and other tests to rule out asthma
- Allergy tests for an individual risk assessment
Source: “Expert Panel Report 3 Summary Report 2007: Guidelines for the Diagnosis and Management of Asthma” and “EPR-3: Full Report 2007” (http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm).

But current national system performance standards fail to capture many of these recommended clinical
standards, particularly asthma education, case management, and environmental remediation.
Additionally, one of the two system guidelines does not capture management of co-occurring conditions
(Figure 13). However, a recently released set of proposed measures by the National Committee for Quality
Assurance (NCQA) and the American Medical Association (AMA)’s Physician Consortium for Performance
Improvement® (PCPI) do address asthma control specifically looking at tobacco smoke exposure in the home,
in addition to other health care measures.

25

W ha t We K now
Figure 13: Recommended Clinical Standards Compared to Performance Measures for Asthma
Asthma Categories

Clinical Standards
NAEPP EPR3 Guidelines for
the Diagnosis & Management
of Asthma

Performance Measures
National Quality Forum
Measures

CHIPRA Children’s Health
Quality Core Measures,
AHRQ

Asthma Measurement

Yes

Yes1

No

Asthma Management:
Asthma Education

Yes

No

No

Written Action Plans

Yes

Yes2, 3

Yes 4, 5

Case Management

Yes

No

No

Management of Co-morbid
Conditions

Yes

No

Yes6

Environmental Remediation

Yes

No

No

Appropriate Medication

Yes

Yes7, 8, 9, 10

Yes11, 12, 13

Hospitalizations & Use of ED

No

Yes14

Yes15, 16

Source: Lyon, M., Rosenbaum, S., Markus, A. Washington, DC: GWU
Asthma Assessment-Percentage of patients who were evaluated during at least one office visit for the frequency (numeric) of daytime and nocturnal asthma symptoms
 anagement plan for people with asthma-Percentage of patients for whom there is documentation that a written management plan was provided either to the patient or the patient’s caregiver or at a minimum, specific written instructions on under
M
what conditions the patient’s doctor should be contacted or the patient should go to the emergency room
3
Home Management Plan of Care Document Given to Patient/Caregiver- Documentation exists that the Home Management Plan of Care (HMPC) as a separate document, specific to the patient, was given to the patient/caregiver, prior to or
upon discharge.
4
From 3rd round of measures that did not meet thresholds for Delphi II scoring, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Percentage of patients for whom there is documentation of a written asthma action management plan was provided
either to the patient or the patient’s caregiver OR, at a minimum, specific written instructions on under what conditions the patient’s doctor should be contacted or the patient should go to the emergency room
5
AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric asthma inpatients with documentation that they or their caregivers were given a Home Management Plan of Care (HMPC) document
6
From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Annual influenza vaccination (all children and adolescents diagnosed with asthma)
7
Suboptimal Asthma Control (SAC) and Absence of Controller Therapy (ACT)- Rate 1: The percentage of patients with persistent asthma who were dispensed more than 5 canisters of a short-acting beta2 agonist inhaler during the same three-month
period. Rate 2: The percentage of patients with persistent asthma during the measurement year who were dispensed more than five canisters of short-acting beta2 agonist inhalers over a 90 day period and who did not receive controller therapy during
the same 90-day period.
8
Use of Appropriate Medications for People with Asthma-Percent of patients who were identified as having persistent asthma during the measurement year and the year prior to the measurement year and who were dispensed a prescription for either an
inhaled corticosteroid or acceptable alternative medication during the measurement year
9
A sthma Pharmacologic Therapy-Percent of all patients with mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative
10
Use of Systemic Corticosteroids for Inpatient Asthma-Percentage of pediatric asthma inpatients (age 2-17 years) who were discharged with principle diagnosis of asthma who received systemic corticosteroids for inpatient asthma.
11
From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Use of appropriate medications for people 5-20 years of age with Asthma-Average number of member controller months
12
AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric inpatients who receive systemic corticosteroids during hospitalizations
13
AHRQ , Joint Commission only measure: Children’s asthma care: percent of pediatric asthma inpatients who received relievers during hospitalization
14
Use of Relievers for Inpatient Asthma-Percentage of pediatric asthma inpatients, age 2-17, who were discharged with a principal diagnosis of asthma who received relievers for inpatient asthma
15
Annual number of asthma patients (> 1 year old) with > 1 asthma-related ER visit
16
From 2nd round of measures that passed Delphi II but not recommended, CHIPRA Children’s Healthcare Quality Measures, AHRQ: Annual number of asthma patients (>1 year old) with >1 asthma-related hospitalization
1
2
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System information exchange and transparency measures are missing. Neither the NIH clinical practice
guidelines nor the system performance measures capture providers’ ability to use HIT in practice, to
exchange data with other clinical providers and health care entities, to exchange data with school
systems and other community programs serving children with asthma, or to report treatment and
management data to payers or public health agencies. For example, there are no measures that
might be used to capture hospital performance in reporting childhood asthma emergency room
cases or inpatient admissions to a child’s primary care physician or to a public health agency. No
measures have yet been developed to determine the effectiveness of reporting from ambulatory
care settings into a public health treatment registry, or the effectiveness of reporting between a
public health registry and payers.

Failure to Address the Indoor Air Environment
Environmental risk factors play a documented role in triggering childhood asthma and interfering
with its control. The evidence to date shows that exposure to cigarette smoke, other irritants (such as
strong odors and nitrogen dioxide) and certain allergens increases children’s risk of developing – or
losing control of – asthma (Figure 14).
Figure 14: Tobacco, Dust Mites Pests and Pets Represent Major Environmental Risk Factors
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EXPOSURE TO TOBACCO SMOKE

INDOOR ALLERGENS & IRRITANTS

 igarette smoke. Children who smoke at least 300 cigarettes per
C
year are three to four times more likely to develop asthma by the
time they graduate high school.xxvi

Dust mites. Exposure to dust mites increases a child’s risk for

 igarette smoking during pregnancy. Women who smoke
C
during pregnancy increase the risk of wheezing (a symptom of
asthma) in their babies who also have worse lung function than
babies whose mothers did not smoke.xxvii Children exposed in utero
who become frequent, regular smokers are nine times more likely to
have new onset of asthma compared to non-exposed smokers.xxviii

 ests and cockroaches. Children who have a high level of
P
cockroach droppings in their home are more likely to have a new
diagnosis of asthma and asthma attacks when they have asthma
than children whose homes have a low level.xxxii

 xposure to environmental tobacco smoke. Children who are
E
exposed to environmental tobacco smoke are at increased risk for
developing asthma, and if they already have asthma, they are more
likely to experience increases in the severity of their symptoms.xxix, xxx

 ets. The evidence on the effect that pets in the home have on
P
developing asthma is unclear but suggests that if a child has asthma,
being around a pet at home may worsen his condition.xxxiii, xxxiv But
other research shows that being around multiple pets, particularly
dogs, early in life might actually protect a child against developing
asthma.xxxv

developing asthma and exacerbating asthma.xxxi

W ha t We K now
Failure to address outdoor air quality in
communities in which children live, particularly
communities facing higher social, economic,
and health risks
The failure to address outdoor air quality perpetuates
children’s exposure to pollutants which can trigger
or exacerbate asthma.
Air pollution, ozone specifically, has been shown to
be associated with asthma triggers and respiratory
problems like wheezing and shortness of breath.xxxvi
In 2007, the EPA estimated that 64 percent of
children lived in counties where the eight hour ozone
standard was violated at least one day a year.xxxvii
Researchers estimate that among children with
asthma, more than 60 percent live in a community
where one or more federal air quality standards are
not being met.xxxviii Outdoor and indoor air quality
are implicitly linked, and this link further reinforces
the need for parallel efforts to reduce pollutants in
the outdoor environment and improve the quality
of the air children breathe outside, as well as inside
their homes and schools. These efforts span a range
of activities, including restricting emissions and
other air pollutants, reducing environmental tobacco
smoke and ensuring schools are built away from
congested roadways.
The absence of a means for monitoring asthma
prevalence and treatment in order to
effectively deploy resources
Underlying these challenges is the absence of an
effective system for monitoring the prevalence of
asthma at the national, state, and community levels
and for gauging the availability or effectiveness of
treatment and its outcome on child health. In 1999,
the President’s Task Force on Environmental Health
Risks and Safety Risks to Children issued a report
entitled “Asthma and the Environment: A Strategy
for Children.” Although the report generally lacked
specific recommendations for federal agency action,
it did call for a coordinated nationwide surveillance
and monitoring system that would allow for data
collection and analysis at all levels. This recommendation
has yet to be implemented.xxxix
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The data in this report are drawn from a series of
important yet disconnected studies that provide
national estimates of prevalence. What is lacking is
a systematic approach to asthma monitoring that

captures information on the prevalence of asthma.
Similarly, there is a lack of a uniform approach to
the development of asthma treatment registries so
that regardless of the community, health care
professionals and health care institutions can work
with public health agencies to maintain essential
information on children who are receiving effective
treatment or children who have experienced
asthma-related emergency department care or
an inpatient admission. Because these basic tools
are absent, it is not possible to know about the
prevalence of childhood asthma or the quality of
care for all communities. Furthermore, it is impossible
for public health agencies to effectively engage
with health care professionals, insurers, schools,
state and local environmental and public housing
agencies, and other relevant agencies, to deploy
resources and improve coordinated interventions
that simultaneously upgrade the accessibility and
quality of care, while also supporting communitywide health education and risk reduction activities.
The absence of a coordinated research strategy
Asthma is a condition that calls for two types of
research: The first is applied research that operates
in routine care and on the ground and allows public
health officials, treating health care professionals,
and community providers to test and evaluate the
effectiveness of different types of interventions.
These interventions include different approaches to
asthma education, different types of care settings, the
impact on adherence rates of different approaches
to care management, or effective ways to triage
children from emergency care episodes into stable
and ongoing care arrangements. The second is basic
and early translational research that enables discovery
and development of therapeutic and diagnostic
modalities. Despite the disproportionately large
number of funded basic and clinical studies, remaining
key research questions that focus on gaining a
greater understanding of elevated childhood asthma
risk include the role of viral or bacterial infections, the
presence of certain antibodies (especially IgE, a class
of antibodies that plays an important role in allergies
and asthma), nutrition and diet, lifestyle, and other
factors. Yet despite the fact that numerous agencies
are involved in asthma research (Figure 15), no single
unified research agenda exists.

Figure 15: Numerous Federal Agencies are Currently Involved in Research
and Policy Initiatives that Address Childhood Asthma
Health &
Human Services,
including:

• Agency for Healthcare Research and Quality
• Centers for Disease Control and Prevention
• Centers for Medicare and Medicaid Services
• Food and Drug Administration
• Health Resources and Services Administration
• National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Institute of Environmental Health Sciences
- National Institute of Child Health and Human Development
- National Center on Minority Health and Health Disparities
• Office of Minority Health

ozone specifically,
has been shown
to be associated
with asthma
triggers and

Housing & Urban Development

respiratory

Environmental Protection Agency

problems like

Department of Education

wheezing and

WHAT WORKS: WE KNOW ENOUGH TO ACT

shortness

Because childhood asthma is a condition with roots that are both biological
and environmental, and because of what it takes to achieve effective control,
asthma can be thought of as an important measure of health system performance.
At the most immediate level, progress in preventing and managing asthma
depends on engaged and empowered families who have the tools they need
to care for their children. Some families have all of the resources they need to
manage asthma without additional help. But many families do not, thus facing
hardships brought on by low family income, a lack of stable insurance coverage,
and residence in communities without adequate primary care resources and
threatened by serious environmental problems.

of breath.

Empowering all families requires the presence of policies that incentivize
high performance and careful coordination among several key health system
players. The elements for improving childhood asthma outcomes include
the following:
• Stable and continuous health insurance;
• H
 igh quality clinical care, case management, and asthma education
available for all children, including those who remain ineligible for
insurance coverage;
• T he ability to continuously exchange information and monitor progress,
using as much as possible health information technology or HIT;
• Reduction of asthma triggers in homes and communities; and
29
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• Learning what works and increasing knowledge.
Undergirding these key players are two foundational activities. The first is an information system that
can yield information about asthma prevalence at the community level, the rate and location of critical
incidents that require follow-up such as a hospital inpatient admission or death, and information on the
proportion of children receiving effective treatment. The second is an overarching research strategy
that produces information about what works in clinical care and asthma management and that adds
to the scientific knowledge base about asthma.
• Stable and continuous insurance coverage
Stable and continuous insurance coverage that makes care affordable and accessible and incentivizes
appropriate utilization and high quality clinical performance is the foundation on which health care rests.
In this regard, because asthma is disproportionately concentrated among lower income children, Medicaid
and CHIP are particularly key. Reforms enacted in 2009 added $33 billion for coverage of children,
enabling programs to reach an additional 4 million children by 2013.xl Together, the two programs both
allow states to expand the reach of health insurance while incentivizing enrollment and retention of
eligible children. As of 2009, 29 million children were enrolled in Medicaid and seven million in CHIP.
The Children’s Health Insurance Program Reauthorization Act (CHIPRA) provides enhanced funding to
permit coverage of children in families with incomes up to 300 percent of the federal poverty level, while
providing federal assistance at regular Medicaid matching rates in states that elect to extend coverage
still further. Were all states to increase coverage to 300 percent of the federal poverty level, an additional
one million children beyond those who are already eligible but unenrolled would be eligible for Medicaid
or CHIP. Of this number, an estimated 180,000 would be previously uninsured children with asthma.
CHIPRA allows states to reach all financially eligible legally resident children during the first five years
of their U.S. residency. CHIPRA further simplifies citizenship documentation requirements and provides
bonus payments to states whose enrollment and retention efforts produce enrollment levels that exceed
their target rates. Full implementation of these reforms could help reach the nearly 600,000 children
with asthma who are eligible for coverage today but remain unenrolled. CHIPRA also provides $100
million in outreach funds, establishes a multi-year clinical quality improvement initiative, and contains
demonstration funding to improve the use of health information technology. Existing Medicaid and CHIP
provider payment policies permit the use of payment arrangements, through direct coverage or the use
of managed care arrangements that incentivize provider adherence to clinical quality standards. National
health system performance measurement tools already contain certain measures of clinical quality
performance related to childhood asthma.
• H
 igh quality clinical care, case management, and asthma education available for all children,
including those who remain ineligible for insurance coverage, and comprehensive and
continuing clinical care in a medical home that contains important links to community and
home settings
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The quality of the clinical care available to children with asthma is critical. Figure 12, above, showed the
elements of recommended clinical practice in the case of pediatric asthma based on the latest NHLBI/ NAEPP
guidelines. These elements boil down to a key imperative: a medical home with skilled and knowledgeable
health care professionals who, acting as a team, continuously monitor the child’s health status over time
and manage the medications that are crucial to improved long-term lung function (not merely episodic
management of attacks). Furthermore, health care professionals must be able to effectively communicate
to children and families at an appropriate literacy level (including having easily comprehensible health
education materials and written asthma action plans), so that families are armed with the knowledge
and information they need to reduce risks and manage their children’s condition. In addition to effective
communication with families, health professionals must be able to communicate with each other in the
treatment and management of asthma, through the appropriate and efficient use of HIT.

The importance of health education in both clinical care and community settings cannot be
overstressed if the aim is to empower families with the knowledge and tools to act. Some families
whose children have asthma are able to put knowledge into practice on their own. Other families,
whose children may be at the highest risk, also face added barriers of poverty, family stress, and
other factors that can limit their ability to turn knowledge into action. For these families, the health
care system needs to be able to support them outside of the office practice and in community
settings through home visits and case management supports. Figure 16 displays the elements of
health education and child and family support, while Figure 17 illustrates the important elements
necessary in school environments to help families and children with both the treatment and
management of asthma.
Figure 16: Key Components of Asthma Health Educationxli
• Individually tailored to child needs, including intensity (research suggests a dose-response)
• Appropriate health literacy level
• Self-management techniques (eg. peak flow) and medication education
• Education about environmental remediation and trigger reduction strategies
in the home
• Conducted in concert with an individually tailored written action plan
Sources: Coffman et al. 2008; Ducharme et al. 2008; Purmort et al. 2000; Wood et al. 2006

Figure 17: Asthma and the School Environmentxlii
• School-based health centers with sufficient time from a school nurse
• Individualized case management from school nurse, including having access to a child’s written
action plan
• Self-management techniques (eg. peak flow) and medication education
• In-service asthma education and trigger reduction education to teachers and school personnel
• Individual and small group health education sessions on asthma management
• Education sessions for parents (for young children) about asthma management (including symptom
identification and education about controller and rescue medication)
Sources: Adams et al. 2000; Levy et al. 2006; Purmort et al. 2000; Webber et al. 2003
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W ha t We K now
• T
 he ability to continuously exchange information and monitor progress, using
as much as possible health information technology.
Knowing which communities experience a particularly great burden of asthma and the
number of children receiving effective treatment, tracking serious incidents such as the
hospitalization or death of a child from asthma, and having the information needed to
deploy community prevention resources are the hallmarks of an effective and engaged
public health system. Asthma registries that can tell public health experts about cases
when they occur, the number of children with diagnosed asthma, and information about
the care that children are receiving, represent essential tools in any significant effort to
reduce and manage childhood asthma. The increased use of HIT provides the opportunity
to simplify the broad adoption of registries. An additional critical role for public health
is translating evidence into information regarding asthma’s prevalence and impact in
order to provide the evidence base for community-wide interventions aimed at reducing
environmental risks such as emissions (including idling around schools), pesticide control,
environmental tobacco smoke, and pest management for housing units.xliii With
nationwide adoption of such a registry system would come far better knowledge
about the prevalence of asthma and the quality of treatment.
Figure 18: Key Components of Asthma Surveillance
• Real time surveillance of asthma events, including patient registries and hospital based surveillance
systems
• Increase the surveillance of causes and triggers of asthma
• Expand information related to asthma disparities by geography of residence, age, insurance status,
country of birth
• Analyze the burden of asthma among smaller populations such as underserved areas,
ethnic subgroups, geographical areas, etc.
• Increase availability of surveillance data for public use and research collaboratives
Sources: Massachusetts and California State Asthma Action Plans

• Reduction of asthma triggers in homes and communities.
Because asthma can be initially triggered or re-triggered by many environmental factors,
their removal from a child’s home environment is essential (Figure 19). This means not
only counseling families about triggers but actually helping them reduce or eliminate
them through the use of special vacuums, air filtration, smoking cessation, special
mattress covers, pest elimination (roach and rodent allergies are a major asthma trigger)
and other home modifications. Seminal NIH-funded multi-site randomized controlled
intervention research studies (NCICAS and ICAS studies) yielded important insight into
the role of integrated pest management and other cleaning strategies to reduce triggers
and control asthma symptoms in the home (Figure 19).

32

Figure 19: Environmental and Home Remediationxliv
• Interventions tailored to individual child’s
skin prick results

• Regular assessment of home environmental
exposures (e.g., every six months for
two years)

• Allergen-permeable covers for child’s
mattress, box spring, pillows

• Routine evaluation of asthma-related
complications (e.g., every two months for
two years)

• HEPA air filters

• A sthma education and management and
directions on how to reduce environmental
exposures to indoor allergens

• Vacuum with a HEPA air filter

• Smoking cessation counseling

Sources: Morgan et al. 2004; Gergen et al. 1999; Greineder et al. 1999

Interventions in community
locations used by children
– playgrounds, schools and
school-yards, and public
housing projects – and the
implementation of policies,
such as those designed to
reduce idling by buses around
schools, have increasingly
been shown to play a role in
reducing asthma triggers. A
growing body of evidence
suggests that interventions
designed to improve the

environments where children play and live can help decrease asthma morbidity.
Together — home and community interventions — have been shown to be effective at improving health, reducing
illness, controlling trips to the hospital emergency department and inpatient admissions, reducing lost school and work
days, and improving children’s ability to engage in the normal activities of childhood.

A Case in Point: Addressing Asthma
in Englewood
Asthma deaths in Illinois are the highest among AfricanAmericans in the United States. Within Chicago, the
Englewood neighborhood just south of downtown
carries more than its share, with asthma-related
hospitalizations that are double the city’s average.
When an entire community shoulders such a heavy
burden of a chronic disease like asthma, solutions
require more than individual action – it must be a
collaborative effort.
The “Addressing Asthma in Englewood” program,
funded by the Merck Childhood Asthma Network, Inc.,
is creating that kind of collaboration. Consider the story
of Melba Miles, proud grandmother to 2-year-old Jamal
who suffers from asthma. With an understanding that
successfully managing asthma involves controlling
indoor and outdoor triggers, part of the Englewood
program includes a neighborhood advisory board that
considers community-wide changes that can improve
asthma control across Englewood. At one meeting of
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the board’s community leaders and caregivers, Melba
expressed her concerns about the effects pesticide
spraying was having on residents’ asthma. The city’s
policy was to spray vacant lots in Chicago, the majority
being in Englewood, without any warning to neighborhood
residents. Melba reported that after nearby lots were
sprayed, Jamal and others with asthma experienced
breathing troubles.
Leaders on the “Addressing Asthma” board took action.
Working with city officials, they created new spraying
policies that would limit exposure to the pesticides.
Now, residents in Englewood and across Chicago can
be put on a “do not spray” list or request to be notified
before their neighborhood is sprayed so they can close
the doors and windows or stay indoors while the
spraying occurs.
The “Addressing Asthma in Englewood” program has
given Melba a voice in improving the health of her
grandson and her community. She now knows how
to manage her grandson’s asthma, and has become
a tireless neighborhood educator and advocate.

W ha t We K now
Examples of Successes & Best Practices
Important examples and important elements of what is working in asthma management and
treatment can be found around the nation (Figures 20).
Figure 20. Asthma Best Practicesxlv
Key Components of a Successful Asthma Program
Tailored Home Environment Remediation: Implementation of Inner-City Asthma Study (ICAS)*
La Red de Asma Infantil
de Merck de Puerto Rico (Puerto
Rico Merck Childhood Asthma
Network Program)

• A tailored environmental evidence-based intervention designed to reduce exposure to
allergens in the home
• Children skin tested for allergen sensitivities using the protocol from the original study
as well as additional local allergens
• Families receive three in-home education sessions on remediating exposure to
common household allergens (dust mites, cockroaches) delivered by an
environmental counselor or community health worker.
• Education on remediation of allergens based on the child’s sensitivities is
also provided, as well as supplies like HEPA filters and dust mite impermeable
mattress covers.

Asthma Outcomes Among
La Red Patients

• Since it’s inception the program has reduced asthma-related emergency department and
hospitalizations by more that one half, from 93 percent to 35 percent for ED use and 27
percent to 9 percent for hospitalizations
• Building on years of community-partnership and demonstrated success, the
San Juan Department of Health is committed to sustaining the program in the
pilot communities and extending it to other clinics in the city

Children’s Health Fund: Childhood Asthma Initiative (CAI) Family Asthma Guide**
Asthma management guide to
help families understand how
asthma happens, what the
triggers are, and how to control
symptoms, including
medication use:

• Provides families tips and guidance on proper medication use and suggestions for
making the best use of doctor’s visits

Asthma Outcomes Among
CAI Patients

• 75 percent of patients had persistent asthma symptoms at the time of initial
assessment – at follow-up, incidence was reduced to 59 percent

• Written in a way that is accessible to low-literacy families
• Includes a sample written action plans families can complete and share with their
doctors and schools to ensure they can control and manage their child’s asthma

• Hospitalization decreased: 18 percent of asthma patients for the 12 months before
initial assessment, down to 3 percent of patients prior to follow-up assessment
• ED use declined from 53 percent of patients during the year prior to initial
assessment to 20 percent of patients prior to follow-up assessment.
*Tailored Home Environment Remediation: Implementation of Inner-City Asthma Study (ICAS). Source: Lara M, et al. (2009)
**Children’s Health Fund: Childhood Asthma Initiative (CAI) Family Asthma Guide.
Source: More information found at: Children’s Health Fund www.childrenshealthfund.org and http://www.childrenshealthfund.org/child-health-care/special-initiatives/childhood-asthma-initiative
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Key Components of a Successful Asthma Program Continued
Urban Health Plan’s Comprehensive Asthma Management Project
The Urban Health Plan (UHP), a
federally qualified health center
in the South Bronx has worked
with more than 6,400 patients to
manage and control their asthma.
The team - Dr. Acklema Mohammed,
MD, an asthma coordinator, six
health educators and a medical
assistant – helps children and
their families by:

• Providing an initial evaluation of the patients asthma, followed by continuous monitoring

Asthma Outcomes Among
UHP Patients

• The average patient had 11.1 symptom free days out of 14

• Creating an individualized asthma action plan for each patient
• Educating the patient and caregiver about the disease and proper use of medication
• Testing the patients for exhaled nitrous oxide, which helps to identify potentially
uncontrolled asthma; allows the team to track patient adherence to the management plan
• If necessary, referring the family to an integrated pest management service provided in
partnership with the NYC Department of Health and Mental Hygiene

• Anecdotally, patients report not having to use the emergency department for care and
having a better understanding of asthma
• Through UHP’s participation in a NYC Department of Health and Mental Hygiene
Project, “Business Case for Quality” the organization’s program demonstrated
significant savings for insurance plans among both pediatric and adult patients

Urban Health Plan’s Comprehensive Asthma Management Project. Source: More information found at: Urban Health Plan, Inc. http://www.urbanhealthplan.org/index.html

Two Foundational Investments: Health Information
Technology and Research
Underlying these investments are two important elements.
The first is a health information system that encompasses
health care, health care financing, and public health.
The system should also build on proven techniques such
as interoperable programs that are capable of rapid
communication about the community-wide presence of
asthma, critical incidents, and the reach of treatment into
the affected population. Such technology could form the
basis of a national system for estimating asthma presence.
It also represents a key source of information for both
applied and scientific research and offers a crucial tool for
developing standards to control environmental threats and
deploying resources into communities that experience
elevated levels of asthma.
The HITECH amendments contained in the American
Reinvestment and Recovery Act (ARRA) provide some $49
billion in investments over a 10-year time period to enable
providers to become meaningful users of HIT and to enable
the adoption and use of interoperable systems that allow
for the sharing of information across the spectrum of clinical
care, engaged patients and improved population and public
health. The ONCHIT is charged with setting national HIT
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policy and with ensuring that these investments advance
both clinical quality and population health, with a particular
focus on conditions that greatly burden health and that
produce significant disparities in health and health care.
• L earning what works and increasing
knowledge.
The second important element is the strategic use
of research to learn more about what works and to
advance knowledge about the causes and effects
of asthma. A well-developed research strategy to
understand better and identify the epidemiology,
pathophysiology, complicating factors and effective
interventions represents an essential support.
Ongoing research, including laboratory, clinical, and
translational efforts aimed at preventing, treating,
and managing asthma, is critical. The commitment to
a robust childhood asthma research agenda includes
coordinated efforts among research partners and
funders, adequate and sustained funding, and the
prioritization of meaningful data collection.

W ha t We K now
Numerous federal agencies are involved in research and
policy initiatives that address childhood asthma. Relevant
research activities can be found within several major
agencies of the Department of Health and Human Services
(Figure 15, above), the Environmental Protection Agency,
the Department of Housing and Urban Development, and
the Department of Education. State and local public health
agencies also play important roles in asthma research.
In 2000, the director of NHLBI, through the NAEPP
Coordinating Committee, was required to identify all
federal programs that carry out asthma-related activities,
develop a federal plan for responding to asthma, and submit
recommendations to Congress on ways to strengthen and
improve coordination of these activities. However, the
Coordinating Committee has not yet published a federal
plan for asthma research and an agenda to implement
this plan. In 2007, the NAEPP successfully issued the third
update to the comprehensive guidelines for the diagnosis
and management of asthma. At the same time, other
federal agencies with an important pediatric asthma
research portfolio, such as the Centers for Disease Control
and Prevention and its Prevention Research Centers, have
not made childhood asthma an explicit priority for their
research programs.
The majority of asthma research in the United States is
funded by the NIH, which expends about 55 percent of its
resources on basic science and the remainder on clinical
and applied research.xlvi While the pathway(s) of translating
basic science findings into refined methods of disease
detection and successful treatment options have been
increasingly supported, the strategies of implementing
evidence-based interventions (EBI) into real world settings
and routine practice have been less well funded and
consequentially have lagged scientifically. The funding
available to link science and service is relatively small.xlvii
Despite the number of existing studies and projects
investigating basic and clinical facets of asthma in general or
pediatric asthma in particular, several key research questions
remain unanswered. These include, but are not limited to,
the role of viral and bacterial infections in early childhood;
causes of acute episodes (e.g., distinct from those associated
with chronic symptoms or simply an exaggeration of the
factors involved in persistent asthma); characteristics of IgE
antibodies that are associated with asthma (e.g., how does
specificity and perhaps affinity of IgE antibodies influence
the risk for asthma?); lifestyle changes including the rise
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in obesity as they influenced the development of asthma.
Given that there have been major changes in the lifestyle
of children over the same period during which asthma has
increased, have these changes influenced the prevalence of
asthma, the severity of symptoms and lung function?
Possible elements of lifestyle changes that may have
influenced asthma include more indoor entertainment
(television, computers, etc. leading to prolonged time sitting
still), decreasing “play” outdoors, changes in diet with the
associated rise in obesity, decreased sunlight leading to
decreased production of Vitamin D, and interaction
between the environment and genetic factors on the
development of the disease.
The answers to these and other questions could be
generated by different types of research depending on
how the questions are framed, including basic science
investigations, clinical randomized and observational studies,
population-based evaluations, and health services research.
Finally, improved management of childhood asthma faces
the challenges of developing science-based methods and
increased funding to implement innovations of EBI into
routine practice in order to improve quality of care.
Investments in these types of studies would require
coordination among federal and state agencies that fund
asthma-related research.

W ha t We Recommend

W ha t We Recommend
A CHILDHOOD ASTHMA POLICY ROADMAP: USING
AVAILABLE TOOLS AND AIMING HIGHER
We have numerous tools for improving asthma treatment and management, while reducing the
burden of asthma on children and families. But we need to aim higher through innovation in existing
programs as well as through active coordination across the major federal agencies whose programs
and strategies influence national asthma policy, particularly for the most at-risk children. The policy
innovations launched today will lay important groundwork for broader transformations to come
through comprehensive health reform.
Today’s federal health programs offer specific policy levers that can be used to enable better
performance for children with asthma. Numerous federal agencies play a crucial role in achieving a
robust response to the great challenges posed by childhood asthma: The United States Department
of Health and Human Services; the United States Environmental Protection Agency; and the United
States Department of Education.
We present specific and feasible policy recommendations for each element identified as key to
improving asthma outcomes:
Stable and Continuous Health Insurance
• M
 ake Medicaid and CHIP enrollment a part of every eligible child’s asthma treatment plan
developed by the child’s health care provider team. With approximately a half million eligible
but unenrolled children with asthma and millions more currently enrolled in Medicaid or CHIP
but at risk for breaks in coverage, Medicaid and CHIP enrollment should be viewed as part
of the treatment plan for every low income child with asthma who otherwise is without
health insurance.
• E ncourage all states to expand Medicaid and CHIP at least to 300 percent of the federal policy
level and to adopt new options to fully cover legally resident children. With expanded eligibility
for coverage comes the potential for more stable and higher quality health care. Today seven
states cover all children with family incomes up to 300 percent of the federal poverty level.xlviii
Expansion of public insurance to reach all eligible children nationally would represent an
enormous advance and one consistent with broader health reform.
• E ncourage all states to adopt Medicaid and CHIP enrollment and retention streamlining reforms,
especially reforms aimed at making enrollment and retention activities possible through
community health care providers, schools, and other locations where children and families
can easily apply for and renew coverage. Outreach funding should be made available through
Medicaid and CHIP, and community providers should partner with hospitals that furnish acute
care to assure that no child is missed.
• M
 ake enhanced asthma treatment and management a specific focus of quality performance
improvement in Medicaid and CHIP. The 2009 CHIP legislation increases the focus on quality
performance improvement among Medicaid and CHIP providers through the development
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of national performance measures and alignment of
these measures with provider payment incentives.
Existing performance measures related to childhood
asthma should be strengthened to more closely align
with NHLBI/ NAEPP clinical treatment guidelines,
particularly in the areas of health education and case
management, and special quality demonstrations
that utilize these measures to incentivize provider
performance could be encouraged.
 igh quality clinical care, case management, and
H
asthma education available for all children, including
those who remain ineligible for insurance coverage
• C
 reate an HHS-led, cross-agency, Administrationwide national plan for changing childhood asthma
outcomes. Despite a wealth of programs and the
importance of HHS programs to ensure accessible
and quality care for children most at risk for asthma
and its consequences, there is no current joint HHS
guidance that comprehensively addresses childhood
asthma, although HHS did issue a strategic plan on
asthma in May 2000. The plan describes the role of
the Department in pursuing priority public health
actions to eliminate disparities and reduce the overall
impact of asthma and addressing urgent needs for
research in order to better understand the cause of
the epidemic and develop preventive interventions to
address these causes. The need for such leadership
and guidance is particularly acute today in the case
of programs overseen by CMS because of the role
of Medicaid and CHIP in financing systemic
improvements in pediatrics. The creation of such
guidance could be led by a Secretarial-level work
group consisting of CMS, the Health Resources and
Services Administration, the Centers for Disease
Control and Prevention, the Indian Health Service,
the Office of the National Coordinator for Health
Information Technology, and in collaboration with
Departments of Education and Housing and Urban
Development and the EPA.

Through a transparent process that involves consumers,
health professionals, payers, and experts in public
health practice, health information, health care financing,
school health, community health, and clinical
treatment for children with asthma, a Secretarial
work group could develop comprehensive guidance.
Such guidance could address the plethora of daily
practical issues that arise when states and localities
attempt to make better and more coordinated use
of separate public programs in order to improve
quality and efficiencies, reduce disparities in health
and health outcomes, reduce public health threats,
and improve overall population health. Practical
guidance would greatly help translate the promise
of public programs into real-world change. Such
guidance could address with clarity:
1. T he clinical services and treatments that Medicaid
and CHIP will pay for and the treatment settings
in which payment can be made;
2. S pecial financing opportunities in the case of
community-based programs and health care
providers that treat a disproportionate number
of children with asthma and that are located in
medically underserved rural and urban communities;
3. Options to finance outreach, health education,
and case management in community settings;
4. D
 eveloping and using public health and practice
registries related to childhood asthma and federal
resources available for such activities;
5. Resources available for mitigating home and
environmental threats;
6. T he meaningful use of HIT in the context of
pediatrics generally and childhood asthma in
particular, because of the extent to which the
quality of asthma care can benefit from improved
health information exchange; and
7. P rivacy and security considerations in adapting
HIT to childhood asthma, which must cross clinical
care, payers, educational systems, environmental
practice, and public health practice.

39

W ha t We Recommend
A far-reaching and visionary cross-agency initiative would do much in our view to encourage
change at every level, while also attracting broad private sector participation because of the cost
of childhood asthma to all payers.
• M
 ake performance improvement in childhood asthma a key aim of community health
centers and the Indian Health Service. Together health centers and the Indian Health
Service (IHS) reach millions of the nation’s children most at risk for asthma. Performance in
pediatric asthma management and treatment should become a basic mechanism for measuring
health care quality improvement in both programs.
The ability to continuously exchange information and monitor progress, using as much as
possible opportunities presented by HIT.
• E
 nhance asthma monitoring through model registries. Asthma registries are essential
to population surveillance, monitoring the accessibility and quality of care as well as patient
outcomes, and tracking critical incidents. The Centers for Disease Control and Prevention, in
collaboration with HRSA’s Bureau of Maternal and Child Health and HHS’ Assistant Secretaries for
Health and Preparedness and Response, could develop special guidance on asthma registries
that encourages the development and implementation of uniform registry systems in all states
and communities with the capability of providing accurate data on prevalence, incident, and
treatment by race, ethnicity, age and gender, and primary language spoken, so that over time,
an accurate and current national and community picture of childhood asthma will emerge.
Reduction of asthma triggers in homes and the communities.
• E ncourage public health agencies, housing authorities and environmental agencies to promote
evidence-based interventions and services that are essential to reducing the many environmental
asthma triggers that lie beyond the control of any one family and fall outside of traditional
“health care” interventions.
Learning what works and increasing knowledge.
• P romote a strengthened and diversified Administration–wide research agenda to include basic,
clinical and translational/implementation investigations.

A far-reaching and visionary cross-agency initiative
would do much in our view to encourage change at
every level, while also attracting broad private
sector participation...
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Numerous federal agencies are involved in asthma research (Figure 15, above), but there is no
coordinated, strategically thought out agenda that spans scientific and applied research and lays
out a broader vision, beginning with what is known today, and focusing on what needs to be
known in practice tomorrow, and where knowledge needs to go over the long term. Recent years
have witnessed a shrinking research budget for asthma (Figure 21). While the overall NIH budget
increased by 6.7 percent between 2005 and 2009 (from $31.42 to $32.32 billion in 2009 dollars),
NIH funding for asthma research decreased by a real dollar decline of approximately 25 percent,
from $318.6 to $252 million (in 2009 dollars). The CDC budget, which totals significantly less than
the NIH budget, has fluctuated between 2005 and 2009 but has hovered at approximately $9
billion (in 2009 dollars). From 2005 to 2009 CDC asthma funding has seen an overall decrease
($35.8 to $30.5 million in 2009 dollars). In addition, examples of duplicated and uncoordinated
efforts abound with many equally notable lapses in strong and practical policy responses.xlix
Figure 21: Federal Asthma Spending NIH and CDC (in 2009 dollars)
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Note that the CDC figures may overstate investments in research since they include all asthma-related activities.
Sources: NIH Research Portfolio Online Reporting Tool (RePORT). USDHHS. Accessed on July 16, 2009 http://report.nih.gov/rcdc/categories/CDC Financial Management Office.
Budget Documents. http://www.cdc.gov/fmo/fmofybudget.htm Accessed July 16, 2009.
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W ha t We Recommend
With the emerging consensus around the importance of comparative and clinical effectiveness
research and in light of the 2009 reforms enacted by Congress to advance such research, it is time to
fulfill the 2000 Congressional directive for a comprehensive asthma research agenda, bringing a fresh
eye to the issue and coordinating the agenda to reach both research that advances daily practice and
research that will deepen knowledge about asthma and its causes.
A robust asthma research agenda can be developed that builds on important research findings, and
positive advances such as the publication of the NHLBI/ NAEPP guidelines and the NIH initiative to
standardize outcome measures used in asthma-related research. However, in addition, adequate
resources must be allocated to support the development of a coordinated research agenda and the
implementation of the proposed agenda in the future.
• Expanded and sustained investment in basic science research is essential.
Asthma treatment and management will benefit enormously from the implementation of
comparative clinical effectiveness research efforts that focus on the treatment and management
of childhood asthma. Of particular importance will be well designed research that is capable
of illuminating the beneficial effects for highest risk children of a comprehensive approach to
childhood asthma treatment and management, with special emphasis on the effects of such an
approach on health care costs, absenteeism at home and work, child health and development,
and overall family functioning. Childhood asthma represents a strong case study of the extent
to which clinical effectiveness research of the type envisioned under the American Reinvestment
and Recovery Act (ARRA), which has already been used for investments in both basic and
applied asthma research, can make a difference in the outcomes of high quality treatment for a
chronic condition that can affect child health and development as well as family well-being. As
the second highest source of pediatric health care spending, asthma represents a crucial area of
focus for comparative effectiveness research. The thrust of comparative effectiveness research
is to compare approaches to treating conditions and identify those strategies that promise both
higher effectiveness and greater efficiencies. Enough is known about the effective management
of asthma to warrant a high focus on comparative effectiveness research as a means of guiding
clinical decision-making, structuring payment incentives, and advancing evidence-based public
health approaches and investment.
These new efforts can be complemented by on-going and centralized tracking of past and
current research investments (Figure 22) from the federal agencies involved in asthma research,
and results inventoried by focus area and stratified by investments that are children-specific.
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Figure 22: An Inventory of National Childhood Asthma Surveys
National Surveys: Childhood Asthma Data Sources
Survey Instruments

Description

Asthma Questions

Sponsor

Behavioral Risk
Factor Surveillance
System (BRFSS)

National, state-based, telephone health & health behavior
survey for adults, data collected monthly (state level analysis)

2008 Questionnaire-optional state
module about Childhood Asthma
Prevalence (37 states & PR participated)

CDC

National Asthma Study
(NAS)

One time survey for adults and children about asthma,
national and four state data collected from 2003-2004
(limited state analysis)

Range of prevalence, health and health
care experience questions for those
with asthma

CDC

Healthcare Cost and
Utilization Project
(H-CUP)

Longitudinal health care and utilization databases, state to
Federal level data, along with private data sources; ongoing
data collection (state, patient-level analysis possible)

KIDS Inpatient Database about pediatric AHRQ
inpatient discharge, asthma associated
hospital data (national analysis)

Medical Expenditure
Panel Survey (MEPS)

Large scale database of surveys (individual and family data
collection), nationally representative sub-sample (use NHIS
sampling) for health care cost and use, accessibility, and health
insurance coverage; ongoing data collection (local level analysis
for insurance possible)

Asthma treatment and management
(including medication) and related
health care utilization questions

AHRQ

National Children’s Study

Nationally representative sample using interviews, exams and
samples to assess the effects of environmental influences on the
health and development of children from 0-21, starting in 2010

Monitors potential causes of asthma
(e.g. maternal health, environment,
samples, interviews)

NICHD

National Health Interview
Study (NHIS)

National cross-sectional household survey on the broad health
of civilian U.S. residents, ongoing every year (national level
analysis)

Range of asthma questions including
prevalence, severity, and health care
utilization

CDC

National Health and
Nutrition Examination
Survey (NHANES)

Nationally representative sample, on health and diet (interviews
& physical exams), continuous interviews on emerging health
needs; data collected every year (national level analysis)

Questions about asthma prevalence as
a health condition

CDC

National Longitudinal
Surveys (NLS)

NLSY79 Children and Young Adults Survey (biological children
of women from NLS79 followed, asked health and life events
questions, followed since 1986); data collected every two years
(cohort specific analysis, not representative)

Health questions include asthma
prevalence

DOL

National Survey for
Children’s Health (NSCH)

National representative telephone survey examining physical
and emotional health of children (0-17); occurred in 2003-2004
and repeated 2007-2008 (state level analysis possible)

Range of asthma questions including
prevalence, severity, and health
care utilization

HRSA
MCHB

National Survey of Children
with Special Health Care
Needs (SLAITS)

Nationally representative telephone survey assessing the
prevalence and impact of special health care needs among
children (0-17) and evaluating changes since 2001; occurred
in 2005-2006

Monitors asthma prevalence and its
effects on social activities

HRSA
MCHB

Youth Behavioral Risk
Surveillance System
(YRBSS)

Nationally representative sample, school based health & health
behavior survey for youth, conducted at national, state, territorial,
tribal, local levels; data collected every two years (local level
analysis possible)

Monitors asthma prevalence
among youth

CDC

Sources: CDC Survey Questions. http://www.cdc.gov/asthma/questions.htm Accessed July 15, 2009; AHRQ Data. http://www.ahrq.gov.data. Accessed July 16, 2009.
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Conc luding T houghts
We know enough to act, and the nation has the resources in place
to act now, regardless of what a reformed health care system will
look like. A national commitment to high quality health care will spur
progress for all children. At the same time, the tools exist today – the
knowledge of what works, public and private health insurance that
can enable strong and integrated health care systems, funding for
improvements in the public health infrastructure, HIT adoption
funding, and funds to grow high quality sources of primary health
care, particularly for the nation’s highest risk children.

M e t hods - In - B r ief

Methods - in - B r ief
Overview
This report was designed to highlight the key issues around what is known and not yet known
about childhood asthma. It also built on the existing knowledge to focus on how to implement
strategies that are known to be effective in reducing asthma morbidity and advance the policy
discussion around providing all children, especially those with asthma, with high quality and efficient
health care. The report was assembled with the careful consideration of the existing evidence
base for childhood asthma, including peer-reviewed journal articles, relevant policy reports, diverse
nationally representative and robust data sets with validated measures to provide appropriate
data with depth and breadth, in addition to in-person meetings and consultations with experts
and guidance of an advisory committee of nationally recognized experts on child health,
childhood asthma, and the insurance and health care landscape in the U.S.

Key Data Sources & Evidence
Expert Group Meetings
• G
 W-MCAN-RCHN CHF Childhood Asthma Policy Roundtable
and Workshop, Grand Hyatt Washington, June 3, 2009, 8:00 AM–12 Noon
www.mcanonline.org/policy_issues/events.html
Nationally Representative Data Sources
• National Health Interview Survey (NHIS)
• Medical Expenditures Panel Survey (MEPS)
• Health Care Utilization Project (HCUP)
• National Survey for Children’s Health (NSCH)
Peer-Reviewed Literature
• Recent, within 5-10 years, widely-cited and recognized as seminal in the field
• M
 ost rigorous study design for interventions and research (e.g., randomized clinical
interventions), including the Inner-City Asthma Study (ICAS) and the National Cooperative
Inner-City Asthma Study (NCICAS)
• C
 ategorized into domains relevant to childhood asthma including: biology, social environment,
behavior, physical environment, policies, services, and clinical care
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Key Policy Documents & Reports
• N
 AEPP: Expert Panel Report 3 Summary Report 2007: Guidelines for the
Diagnosis and Management of Asthma and EPR-3: Full Report 2007
• A
 merican Lung Association: A National Asthma Public Policy Agenda,
January 2009
• P ublic Health Foundation: We Can Do Better: Improving Asthma
Outcomes in America, January 2009
• R
 AND Health: Improving Childhood Asthma Outcomes in the United
States: A Blueprint for Policy Action, 2001
• A
 sthma UK: Where Next in Clinical Asthma Research? An Asthma UK
Consultation on Clinical Asthma Research Strategy, 2004
• A
 ction Against Asthma: A Strategic Plan for the Department of Health
and Human Services, May 2000
• P utting the GIP Report in Motion: A Plan of Action for the National
Asthma Control Initiative, April 2009
• P resident’s Task Force on Environmental Health Risks and Safety Risks to
Children. Asthma and the Environment: A Strategy to Protect Children.
January 28, 1999 Revised May 2000
Special Technical Note about the Data Source & Methods Used for the GW
2006 MEPS Expenditure Analysis (Dor, A., Richard, P., and Tan, E., 2009)
GW used the 2006 Medical Expenditure Panel Survey (MEPS) to examine
health care expenditures of children with asthma and determine health care
expenditures of children conditional of having asthma. This analysis used
the CDC definition of children ever diagnosed with asthma, which is
different from the AHRQ definition used in the Kim et al. analysis of three
years of MEPS data (Kim et al. (2009). Health Care Utilization by Children
with Asthma, Preventing Chronic Disease Vo. 6: No. 1) which relates to direct
medical expenditures for children who receive any asthma or COPD treatment
in the past 12 months.
The 2006 MEPS is a set of large-scale family, individual, medical provider,
and employer surveys across the United States. The MEPS is a nationally
representative survey of health care use, insurance coverage, medical
expenditures, sources of payment, demographic and socioeconomic variables
for the U.S. civilian non- institutionalized population. The 2006 MEPS collects
information from 34,145 individual respondents including 9,633 children
below age 18 of which 1,022 were diagnosed with asthma. Within this
sample, 796 children had persistent asthma during the past 12 months
and 414 children experienced an asthma attack. Children are said to have
persistent asthma if the child still had asthma or if the child had experienced
an episode of asthma or an asthma attack in the past 12 months. Using the
MEPS sampling weights, GW estimated that nationally 10.8 percent or a total
of eight million children ages 0 to 17 have asthma.
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